Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.
about
New simulation approach using classical formalism to water nuclear magnetic relaxation dispersions in presence of superparamagnetic particles used as MRI contrast agents.Modulating water-exchange rates of lanthanide(III)-containing polyaminopolycarboxylate-type complexes using polyethylene glycol.Strategies for optimizing water-exchange rates of lanthanide-based contrast agents for magnetic resonance imaging.B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation.Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents.Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agentsSubstituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.Toward the Design of MR Agents for Imaging β-Cell Function.Challenges for Molecular Neuroimaging with MRI.Lower ligand denticity leading to improved thermodynamic and kinetic stability of the Gd3+ complex: the strange case of OBETA.Analytical methods for characterizing magnetic resonance probes.Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.Strategies for the preparation of bifunctional gadolinium(III) chelators.New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators - Reaction of amines with a novel electrophilic 3,2-HOPO precursorMetal-containing and related polymers for biomedical applications.Catechol-based biomimetic functional materials.The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.Optically switchable chelates: optical control and sensing of metal ions.Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agents.Synthesis and Characterization of Ligands and their Gadolinium(III) ComplexesStructure, Dynamics, and Computational Studies of Lanthanide-Based Contrast AgentsNew tris-3,4-HOPO lanthanide complexes as potential imaging probes: complex stability and magnetic properties
P2860
Q30569793-030E0488-CFE8-4C26-B4CD-F85DA53FB7ECQ30616187-9801085C-720B-49FE-8B80-8AABFC0845FCQ30660032-8C7EA4C9-BB87-4440-9F27-425FA602A4E8Q30752868-469F4D87-F361-41F1-A390-A460B6E7D0FFQ30901328-77BEBF99-02B1-4C15-B560-9DB5C8BB1B81Q31036923-A9E08234-88DC-4C68-BD26-9EF6CB8CA1ABQ31049021-B418C62E-50B2-47B0-B93E-EB6976527DC1Q31062213-606CE3E8-C1C6-4865-9CC1-F2FBF40D614BQ33463644-72012599-3BE4-4F1E-A06A-59709AFAA517Q33649688-A096EDB4-34E4-44E2-9C17-705E6D17E03CQ33680025-2A1A5720-F98C-4558-BBF2-7FD5DA55AC8EQ34276804-745BC2E9-D5BC-4BA3-8B9B-6EEE58E4BB6DQ34280357-C776637E-8E60-4B3C-8582-E631D4AA559CQ35665118-7B5D6139-E13C-4E8E-9C1A-9EF868AB1B76Q35777941-B38420C3-5975-4F25-8EB3-5EE3391AFA14Q36364649-85F585C7-7654-4928-8DEB-912652320BCBQ37201391-0C7D41C9-2FDD-4EC7-91CF-E3E5FC7A750CQ38062517-BCBD2E47-1FDB-4594-98B6-AE3296D951A3Q38080002-58401658-1120-4FF7-AA01-162AC900FFC2Q42403751-3E9375CE-E53F-4528-A336-28D0B130B7EDQ51803975-372CED26-9004-4E14-93F3-753FB4DA3E93Q57340454-BAE5304F-8D0B-47ED-BAD2-9DBBF3B40D43Q57391311-010E4B20-368D-4ADB-BCB0-9C6EF940B075Q58374529-AC258369-8187-47E4-8C9A-48DF70975431
P2860
Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Syntheses and relaxation prope ...... idinonate MRI contrast agents.
@ast
Syntheses and relaxation prope ...... idinonate MRI contrast agents.
@en
type
label
Syntheses and relaxation prope ...... idinonate MRI contrast agents.
@ast
Syntheses and relaxation prope ...... idinonate MRI contrast agents.
@en
prefLabel
Syntheses and relaxation prope ...... idinonate MRI contrast agents.
@ast
Syntheses and relaxation prope ...... idinonate MRI contrast agents.
@en
P2093
P356
P1433
P1476
Syntheses and relaxation prope ...... idinonate MRI contrast agents.
@en
P2093
Raymond KN
P304
P356
10.1021/IC000563B
P407
P577
2000-12-01T00:00:00Z